Immunization has saved an estimated 150 million lives since 1974 — six lives every minute. Vaccination accounts for 40 ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Vaxcyte (NasdaqGS:PCVX) with a Overweight ...

The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.

This downside came after Vaxcyte reported mixed results from a phase II study on its investigational pneumococcal conjugate vaccine (PCV) in healthy infants. Adding to this headwind, the broader ...

Expanded recommendations from the Advisory Committee on Immunization Practices on the use of pneumococcal conjugate vaccines may improve disease prevention among adults aged between 50 and 64 years.

Given the uncertain regulatory environment, I am downgrading Vaxcyte's stock to "Hold" until there's more clarity on the FDA's stance on PCV vaccines. Phase 2 dose-finding study evaluating the ...

No serious adverse events were considered to be related to the study vaccines. Post-dose 3, the VAX-24 Mid dose met target precedent Phase 2 non-inferiority (NI) criteria on relative ...

These included: Capvaxive is Merck’s FDA-approved 21-valent pneumococcal conjugate vaccine indicated for active immunization for the prevention of invasive disease and pneumonia in adults 18 years of ...

vaccine, four doses of the pneumococcal conjugate vaccine, and five doses of the DTaP (diphtheria, tetanus and pertussis) vaccine. Nagappan said it’s important to get children to get their ...